Roche CEO: InterMune perfect strategic fit

Now watching

Next video starts in : 7 Play

Roche CEO: InterMune perfect strategic fit

Roche CEO: InterMune perfect strategic fit
Replay video
Up next

The real issue around a Fed rate hike

Unlock your personal NFL Now stream by signing in to NFL.com

Roche CEO: InterMune perfect strategic fit

by CNBC Videos 4:14 mins

CNBC's Meg Tirrell speaks to Roche CEO Severin Schwan, and InterMune CEO Daniel Welch, about Roche's $8.3 billion acquisition of InterMune and the opportunity for the drug Esbriet in the U.S.

View Comments (0)